SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION vs qXR-CTR

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

by DIACOUSTIC MEDICAL DEVICES (PTY)

qXR-CTR

by Qure.ai

AI Verdict

Tool A, SENSICARDIAC MOBI, assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope. In contrast, Tool B, qXR-CTR, automates the measurement of the cardiothoracic ratio from chest X-ray images to assess heart size and potential heart failure risk. While both are cardiology AI tools, they utilize different data modalities (acoustic vs. imaging) and focus on distinct aspects of cardiac assessment.

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if your primary need is real-time or near real-time AI-assisted analysis of acoustic heart signals to differentiate between physiological and pathological heart murmurs. This tool is ideal for clinicians who require immediate decision support during patient auscultation to identify and characterize suspected murmurs at the point of care.

View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →

Choose qXR-CTR if…

Choose qXR-CTR if your focus is on automating the measurement of the cardiothoracic ratio (CTR) from chest X-ray images to assess heart size and potential heart failure risk. This solution is best suited for radiology and cardiology departments seeking to streamline the analysis of existing imaging data for cardiac enlargement indicators.

View qXR-CTR →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	qXR-CTR
Pricing	Contact for pricing	Unknown
Deployment	Hosted server environment (Linux OS) with a mobile application interface	Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app.
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

SensiCardiac Mobi (Tool A) offers a mobile application with guided auscultation and real-time analysis, directly assisting physicians at the point of care. Its FDA clearance documentation notes improved usability compared to predicate devices, with users scoring it highly for ease of use. While qXR-CTR (Tool B) integrates into radiology workflows, some feedback on Qure.ai's broader qXR product suggests it can sometimes increase cognitive load due to overcalling findings.

Clinical Value

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

SensiCardiac Mobi (Tool A) provides direct diagnostic assistance for heart murmurs by differentiating between physiological and pathological sounds, aiming to reduce unnecessary specialist referrals. This offers immediate clinical impact at the point of care. While qXR-CTR (Tool B) automates a crucial measurement for heart size and heart failure risk, Tool A's direct diagnostic aid for a specific condition in real-time presents a more tangible and immediate clinical benefit in many primary care scenarios.

Pricing & Value

qXR-CTR

Both tools have undisclosed pricing, making a direct cost comparison impossible. However, Qure.ai's broader qXR product, which includes qXR-CTR, has demonstrated cost-effectiveness in health technology assessments, indicating a strong value proposition by addressing human resource constraints and reducing diagnostic delays. SensiCardiac Mobi (Tool A) lacks any publicly available information regarding its pricing or demonstrated cost-effectiveness.

Enterprise Readiness

qXR-CTR

qXR-CTR (Tool B) offers superior enterprise readiness with flexible deployment options including cloud, on-premise, and hybrid, along with extensive integration capabilities with major PACS and RIS systems. It also supports multiple operating systems and languages. SensiCardiac Mobi (Tool A) is described as a 'Hosted server environment (Linux OS) with a mobile application interface,' which suggests less deployment flexibility for large-scale enterprise integration.

Innovation

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

SensiCardiac Mobi (Tool A) demonstrates a more innovative application of AI by directly augmenting a physician's physical examination through real-time heart murmur diagnosis using acoustic signals from an electronic stethoscope. This direct, interactive diagnostic support at the point of care is a novel approach. While qXR-CTR (Tool B) provides valuable automated measurements from images, this is a more common and established application of AI in radiology.

Support & Docs

qXR-CTR

Qure.ai (Tool B's company) provides comprehensive support, including dedicated client success partners, email support with a stated response time, in-app support, 24/7 availability, and personalized onboarding and education programs. SensiCardiac Mobi (Tool A) has no publicly available information regarding its customer support structure or documentation, making it impossible to assess this dimension for Tool A.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	qXR-CTR
Product Name	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	qXR-CTR
Primary Function	Assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope to differentiate between physiological and pathological sounds.	Automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk.
Company	DIACOUSTIC MEDICAL DEVICES (PTY)	Qure.ai Technologies
Main Categories	Cardiology AI, Clinical Decision Support & Reference	Cardiology AI, Radiology & Imaging AI
Target Specialties	Cardiology, Internal Medicine, Pediatrics	Cardiology, Radiology

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION and qXR-CTR.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows for patient assessment?

SensiCardiac Mobi integrates into the physical exam by utilizing a mobile application and an electronic stethoscope to acquire and analyze heart sounds at the point of care, complementing the physician's assessment. qXR-CTR automates the measurement of the cardiothoracic ratio from chest X-ray images, fitting into a radiology workflow where X-rays are reviewed for cardiac assessment and provides annotated X-rays and structured reports in DICOM and JSON formats.

What is the depth of EHR integration for each tool, particularly regarding the transfer of findings and measurements?

SensiCardiac Mobi uses a mobile application for data capture and display, and qXR-CTR provides structured reports in DICOM and JSON formats, integrating seamlessly into existing radiology workflows. While qXR-CTR is designed to integrate with PACS and modalities, the specific depth of integration for transferring these findings and measurements directly into an EHR for SensiCardiac Mobi is not detailed in the provided descriptions.

What clinical context or evidence supports the diagnostic utility and accuracy of each tool?

SensiCardiac Mobi assists in diagnosing heart murmurs by analyzing acoustic heart signals to differentiate between physiological and pathological sounds using its proprietary Sensi Diagnostic Heart Murmur Algorithm. qXR-CTR automates the measurement of the cardiothoracic ratio from chest X-ray images, with clinical studies demonstrating its performance in measuring cardiac and thoracic diameters, and it is intended to aid in assessing heart size and potential heart failure risk.

For which specific clinical specialties and scenarios is each tool most beneficial?

SensiCardiac Mobi is beneficial for Cardiology, Internal Medicine, and Pediatrics, particularly for assisting in the diagnosis of heart murmurs during auscultation. qXR-CTR is suited for Cardiology and Radiology specialties, aiding in the assessment of heart size and heart failure risk through automated cardiothoracic ratio measurements from chest X-rays.

What is the expected learning curve for physicians and their support staff to effectively use each tool?

SensiCardiac Mobi requires users to operate a mobile application and a compatible electronic stethoscope to record heart sounds at specific auscultation positions. For qXR-CTR, as an AI-powered software for automated measurement, the learning curve would likely involve understanding its automated output and integrating it into existing radiological or cardiological image review processes, with studies on similar AI tools suggesting improved efficiency along a learning curve.

What audit trail capabilities do these tools offer to track usage, data access, and diagnostic outputs?

The provided descriptions for SensiCardiac Mobi do not explicitly detail its audit trail capabilities. For qXR-CTR, Qure.ai mentions security features including audit logs.